Laurus Labs Ltd

BSE : LAURUSLABS07 Feb 2025
Pharmaceuticals
+5.10 (+0.80%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Laurus Labs Ltd
Laurus Labs Ltd
Pharmaceuticals
BSE : LAURUSLABS07 Feb 2025
+5.10 (+0.80%)
1D
1M
6M
1Y
5Y
All

Laurus Labs Ltd - Share Price & Details

Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
59.52%
Upper Circuit
Lower Circuit
P/E TTM
137.42
P/B Ratio
8.03
Traded Value(Cr)
0.04
EPS TTM
4.63
Book value
Dividend
0.13%

Invest in Laurus Labs Ltd at ZERO Brokerage for 30 days

Price Performance

8.19 %
1 Wk
6.09 %
1 M
28.17 %
3 M
59.52 %
1 Y
3.45 %
YTD

Traded Volume Movement

Technical Details

Support 3
623
Support 2
629
Support 1
635
Pivot Point :
641
Resistance 1
648
Resistance 2
653
Resistance 3
660

Reports

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Laurus Labs Ltd
₹641.35(+5.10/0.80%)
641.35+5.1034,304.0159.52137.428.03
Bliss GVS Pharma Ltd
₹149.70(-3.90/-2.54%)
149.70-3.901,618.4928.3219.951.58
Amrutanjan Health Care Ltd
₹659.70(-11.10/-1.65%)
659.70-11.101,939.3317.0140.806.51
Astrazeneca Pharma India Ltd
₹7,639.45(+45.90/0.60%)
7,639.45+45.9018,983.889.47147.4827.94
Abbott India Ltd
₹29,796.40(+694.45/2.39%)
29,796.40+694.4561,841.642.9546.3417.56
53.24+1.69395.04-18.4644.838.77

About Laurus Labs Ltd

Laurus Labs Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 34304.01 crores. It has reported a sales of Rs. 1414.52 crores and a net profit of Rs. 121.32 crores for the quarter ended December 2018. The company management includes Ravindranath Kancherla, CHAVA SATYANARAYANA,VENKATA RAVI KUMAR VANTARAM,Aruna Bhinge,Rajesh Koshy Chandy,Ravindranath Kancherla,Venkata Lakshmana Rao Chunduru,Karnam Sekar,KRISHNA CHAITANYA CHAVA,G Venkateswar Reddy,Soumya Chava,Ramesh Subrahmanian (Laurus Labs Ltd) among others.
Chairman
Ravindranath Kancherla
Registered office
Plot No 21 Jawaharlal Nehru,Pharma City Parawada,Visakhapatnam,Andhra Pradesh,531021
FAX :91-891-3061270
Background
Incorporation Year2005
Face Value₹2
Market Lot1

Latest News

📢 Sensex declines 197 points at the close; Nifty ends above 77,800

📈 Domestic benchmark indices closed on a negative note on 7 February 2025.
📢 At 3:30 PM, the Sensex tanked by 197.97 points or 0.25% at 77,860.19, and the Nifty was down 43.40 points or 0.18% at 23,559.95.
📊Among sectoral, Nifty Metal (⬆️2.66%) turned out to be the best performer while Nifty PSU Bank (⬇️1.38%) saw considerable selling.
07 Feb 2025 | 03:49 PM

Sensex, Nifty jittery as RBI delivers first rate cut since 2020

Sensex and Nifty initially rose following the Reserve Bank of India's 25-basis-point repo rate cut to 6.25%, its first cut since May 2020, but soon returned to opening levels, hovering near flatline, as investors reacted to the move aimed at boosting economic growth amid slowing momentum and subdued corporate earnings.
07 Feb 2025 | 10:49 AM

Sensex, Nifty flat ahead of RBI MPC verdict

Sensex and Nifty opened near the flatline on February 7, with investors on edge ahead of RBI's monetary policy decision. With growth slowing and the government already cutting personal income tax, RBI is expected to deliver its first rate cut since May 2020. At 9.18 AM, the Sensex was down 71 points or 0.09 percent at 77,986, and the Nifty was down 13 points or 0.06 percent at 23,589.
07 Feb 2025 | 09:49 AM

📢 Sensex declines 197 points at the close; Nifty ends above 77,800

📈 Domestic benchmark indices closed on a negative note on 7 February 2025.
📢 At 3:30 PM, the Sensex tanked by 197.97 points or 0.25% at 77,860.19, and the Nifty was down 43.40 points or 0.18% at 23,559.95.
📊Among sectoral, Nifty Metal (⬆️2.66%) turned out to be the best performer while Nifty PSU Bank (⬇️1.38%) saw considerable selling.
07 Feb 2025 | 03:49 PM

Sensex, Nifty jittery as RBI delivers first rate cut since 2020

Sensex and Nifty initially rose following the Reserve Bank of India's 25-basis-point repo rate cut to 6.25%, its first cut since May 2020, but soon returned to opening levels, hovering near flatline, as investors reacted to the move aimed at boosting economic growth amid slowing momentum and subdued corporate earnings.
07 Feb 2025 | 10:49 AM

How to buy Laurus Labs Ltd shares on nse?

To buy Laurus Labs Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Laurus Labs Ltd share price today?

The Laurus Labs Ltd shares price on nse is Rs.641.35 today.

What is the market cap of Laurus Labs Ltd shares on BSE ?

The company has a market capitalization of Rs.34304.01Cr

What is the PE & PB ratio of Laurus Labs Ltd shares ?

PE is 137.42 and PB is 8.03

What is the 52 Week High and Low of Laurus Labs Ltd shares?

Laurus Labs Ltd stock price high: Rs.646.25 Laurus Labs Ltd stock price low: Rs.372.2

What is the market capitalisation of Laurus Labs Ltd?

The market capitalization of Laurus Labs Ltd is 16447.71 crore. 

 

What is the dividend history of Laurus Labs?

For the last year, ending in March 2022, the company declared a dividend of 100.00% equity, which amounted to Rs. 2 per equity share. For the last 5 years, the company has shown consistency in dividend declaration.

How does Laurus Labs generate revenue?

Laurus Labs primary generation of revenue comes out of its synthesis and active pharmaceutical ingredient business operations. These are known as its API businesses, accounting for over 40% of its entire revenue. 

 What is the growth potential of Laurus Labs?

In the pharmaceutical sector, Laurus Labs has seen growth with its synthesis business and its active pharmaceutical ingredients business growing 210% and 49%, respectively. This has put the company on a journey of future optimism and development. 

 

What is the future outlook for Laurus Labs in the pharmaceutical industry?

In January 2023, the shares of Laurus Labs saw a rise of 5.3%. With a strong boost in demand for its niche businesses that produce the chemicals and other important ingredients required for certain drugs, the future of Laurus Labs looks bright. The company has also made bids for expansion and has shown interest in the purchase of an over 70% stake in Richcore Life Sciences. 

 

What are the major products and services offered by Laurus Labs?

The major products that Laurus Labs produces are specific ingredients and chemicals for drugs, and Hepatitis C and oncology drugs. 

 

What are the key markets and regions where Laurus Labs operates?

The company operates from its headquarters in Hyderabad, India, but has manufacturing and research labs at Bangalore and Visakhapatnam, as well as in Hyderabad itself. It also has an R&D center in the USA. It is a multinational corporation and serves a global platform via its subsidiaries in the USA and Europe. 

 

What is the dividend policy of Laurus Labs?

The company holds a good and consistent track record for hanging out dividends, giving them regularly for the past five years. 

 

Click here to see your activities